Skip to content

Study on early screening techniques for perception abnormalities in schizophrenia

Study on early screening techniques for perception abnormalities in schizophrenia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200058124
Enrollment
Unknown
Registered
2022-03-30
Start date
2022-04-15
Completion date
Unknown
Last updated
2023-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

Psychiatric clinical high-risk group:None
First episode schizophrenia group:None
Healthy control group:None

Sponsors

Beijing Anding Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1.Inclusion criteria for clinically high-risk groups of psychiatric disorders: 1) 16-40 years old, junior high school education and above; 2) Right-handed, normal vision and hearing, no previous visual and auditory system diseases; 3) In line with the diagnostic criteria of the psychosis risk syndrome in the psychiatric risk syndrome interview; 4) Not treated with antipsychotic drugs. 2.Inclusion criteria for first episode schizophrenia: 1) 16-40 years old, junior high school education and above; 2) Right-handed, normal vision and hearing, no previous visual and auditory system diseases; 3) Meet the diagnostic criteria of DSM-V schizophrenia; 4) First attack, course of disease =2 years; 5) Without systematic antipsychotic medication (continuous regular medication = 1 month or irregular medication = 3 months) 3.Inclusion criteria for normal control group: 1) 16-40 years old, junior high school education and above; 2) Right-handed, normal vision and hearing, no previous visual and auditory system diseases; 3) The use of MINI assessment does not meet any diagnostic criteria for mental disorders.

Exclusion criteria

Exclusion criteria: 1. Exclusion criteria for clinical high-risk groups of psychosis: 1) Now or in the past, he has been diagnosed as schizophrenia, schizoaffective disorder, delusional disorder, bipolar disorder or depressive disorder, delirium, dementia or other cognitive disorders, mental development disorder (IQ < 70), physical disease or mental disorders caused by psychoactive substances; 2) History of severe or unstable nervous system and other somatic diseases clearly diagnosed; 3) Excitement, impulse, non cooperation and researchers think that subjects may commit suicide or violence during the research process; 4) Those who have received electric convulsion treatment or electromagnetic stimulation treatment within six months; 5) History of alcohol and drug abuse or dependence; 6) Pregnant or lactating women and women who are pregnant and clearly indicate pregnancy preparation during follow-up; 7) Participated in other scientific research and treatment in recent 2 months; 2. Exclusion criteria for the first episode of schizophrenia: 1) Now or in the past has been diagnosed as schizoaffective disorder, delusional disorder, bipolar disorder or depressive disorder, delirium, dementia Stupid or other cognitive disorders, intellectual development disorders (IQ < 70), physical diseases or mental disorders caused by psychoactive substances; 2) History of severe or unstable nervous system and other somatic diseases clearly diagnosed; 3) Excitement, impulse, non cooperation and researchers think that subjects may commit suicide or violence during the research process; 4) Those who have received electric convulsion treatment or electromagnetic stimulation treatment within six months; 5) History of alcohol and drug abuse or dependence; 6) Pregnant or lactating women and women who are pregnant and clearly indicate pregnancy preparation during follow-up; 7) Participated in other scientific research and treatment in recent 2 months; 3. Exclusion criteria for normal control group: 1) Previous history of mental illness, family history and mental retardation (IQ<70); 2) A clear diagnosis of severe or unstable nervous system and other chronic somatic diseases; 3) History of alcohol and drug abuse or dependence; 4) He has participated in other scientific research and treatment in recent 2 months.

Design outcomes

Primary

MeasureTime frame
EEG event-related potentials;Cognitive function;Clinical information;Magnetic resonance imaging;

Countries

China

Contacts

Public ContactMa Xin

Beijing Anding Hospital, Capital Medical University

maxinanding@vip.163.com+86 10 58303002

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026